The global empty capsules market is estimated to grow at a CAGR of 7.2% during the forecast period, to reach USD 2.13 Billion by 2021. More than 90% of the market is accounted by traditional gelatin capsules. However, the potential dangerous of disease, the nature of instability, religious or dietary restrictions as well as stringent regulatory frame works are expected limit the growth of this market to a certain extent. On the contrary, non-gelatin capsules are growing due to those factors.
The non-gelatin empty capsule is classified into three types by materials, namely cellulose ester, plant polysaccharide and plant starch. Hydroxypropyl methyl cellulose (HPMC) capsules, which belongs to first type, is the main part of the industry and grow fast these years. Plant polysaccharide or starch capsule shared small part of capsules market caused by high cost or immature technology. With the development of research, starch capsules are expected to grow fast for further days.
As traditional gelatin capsules, non-gelatin capsules market is subsegmented into antibiotic and antibacterial drugs, vitamins and dietary supplements, and other therapeutic applications.
Geographically, the Non-Gelatin Empty Capsules market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded a major share of the market. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to growth in the pharmaceutical and nutraceutical industries along with less stringent regulations in the nutraceutical industry, increasing number of new healthcare facilities, and rising healthcare awareness.